Human EGLN1 ELISA Kit (V2LY-0626-LY3108)

Tang, J., Deng, H., Wang, Z., Zha, H., Liao, Q., Zhu, C., ... & Xiao, W. (2022). EGLN1 prolyl hydroxylation of hypoxia-induced transcription factor HIF1α is repressed by SET7-catalyzed lysine methylation. Journal of Biological Chemistry, 298(6).

Gangat, N., Oliveira, J. L., Porter, T. R., Hoyer, J. D., Al-Kali, A., Patnaik, M. M., ... & Tefferi, A. (2022). Erythrocytosis associated with EPAS1 (HIF2A), EGLN1 (PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience. Haematologica, 107(5), 1201.

Reggiani, F., Sauta, E., Torricelli, F., Zanetti, E., Tagliavini, E., Santandrea, G., ... & Sancisi, V. (2021). An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma. Molecular Cancer, 20(1), 1-6.

Bonnin, A., Gardie, B., Girodon, F., Airaud, F., Garrec, C., Bézieau, S., ... & Lellouche, F. (2020). A new case of rare erythrocytosis due to EGLN1 mutation with review of the literature. La Revue de Medecine Interne, 41(3), 196-199.

Moore, J. A., Hubbi, M. E., Wang, C., Wang, Y., Luo, W., Hofmann, S., & Rambally, S. (2020). Isolated Erythrocytosis Associated With 3 Novel Missense Mutations in the EGLN1 Gene. Journal of Investigative Medicine High Impact Case Reports, 8, 2324709620947256.

Liu, G., Zhao, W., Zhang, H., Wang, T., Han, Z., & Ji, X. (2020). rs1769793 variant reduces EGLN1 expression in skeletal muscle and hippocampus and contributes to high aerobic capacity in hypoxia. Proceedings of the National Academy of Sciences, 117(47), 29283-29285.

Yasukochi, Y., Nishimura, T., Ugarte, J., Ohnishi, M., Nishihara, M., Alvarez, G., ... & Aoyagi, K. (2020). Effect of EGLN1 genetic polymorphisms on hemoglobin concentration in Andean highlanders. BioMed research international, 2020.

Price, C., Gill, S., Ho, Z. V., Davidson, S. M., Merkel, E., McFarland, J. M., ... & Hahn, W. C. (2019). Genome-wide interrogation of human cancers identifies EGLN1 dependency in clear cell ovarian cancers. Cancer research, 79(10), 2564-2579.

Heinrich, E. C., Wu, L., Lawrence, E. S., Cole, A. M., Anza‐Ramirez, C., Villafuerte, F. C., & Simonson, T. S. (2019). Genetic variants at the EGLN1 locus associated with high‐altitude adaptation in Tibetans are absent or found at low frequency in highland Andeans. Annals of human genetics, 83(3), 171-176.

Graham, A. M., & McCracken, K. G. (2019). Convergent evolution on the hypoxia-inducible factor (HIF) pathway genes EGLN1 and EPAS1 in high-altitude ducks. Heredity, 122(6), 819-832.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols